Should these opioids be schedule 1 drugs? episode artwork

EPISODE · Oct 6, 2022 · 9 MIN

Should these opioids be schedule 1 drugs?

from POLITICO's Pulse Check · host POLITICO

More than 100 researchers, scientists and public health professionals want fentanyl-related substances to no longer be Schedule I drugs — saying a different classification has the potential to unlock research on those drugs to treat opioid addiction or other mental health conditions. Daniel Payne and Ben Leonard unpack a Tuesday letter sent to the White House. Plus, Jason Gibbons, a postdoctoral fellow at Johns Hopkins University, explains a new study on using buprenorphine in Medicare patients. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Oct 6, 2022

Embed this episode

NOW PLAYING

Should these opioids be schedule 1 drugs?

0:00 9:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of POLITICO's Pulse Check?

This episode is 9 minutes long.

When was this POLITICO's Pulse Check episode published?

This episode was published on October 6, 2022.

Can I download this POLITICO's Pulse Check episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!